< Back to all clusters
[HEALTH] · United States, United Kingdom · 3 sources

started · updated

FDA removes black‑box warnings on menopause hormone therapy

In November 2025 the U.S. Food and Drug Administration began stripping black‑box warnings from menopausal hormone‑therapy products, reversing a policy that had been in place since the early 2000s. The change follows re‑analyses of the Women’s Health Initiative study, which originally halted hormone use after suggesting higher risks of heart disease, breast cancer, stroke and pulmonary embolism. New research supports a "timing hypothesis" that the therapy is safer for women in their late 40s and early 50s, prompting medical groups to again recommend it for many patients.

The regulatory shift coincides with a surge in public interest. Media outlets such as NPR, the Deccan Herald and EatingWell have highlighted the debate, while online searches for menopause information have risen sharply. A recent United Kingdom survey of more than 900 perimenopausal women found that 90% received no school education on menopause, only 2.1% felt well‑informed, and 85% turned to the internet once symptoms began. The findings underscore a broader push for better education and workplace accommodations for women navigating menopause.

Entities

Food and Drug Administration · Menopause hormone therapy · NPR · United Kingdom · Women’s Health Initiative

Claims

What the coverage asserts, and how well corroborated each claim is across sources.

  • [○ 1 SOURCE] NPR initiated the current public discourse on menopause hormone therapy. www.archynetys.com
  • [○ 1 SOURCE] Only 2.1% of surveyed UK perimenopausal women said they were very informed about menopause. vajenda.substack.com
  • [○ 1 SOURCE] The FDA began removing black‑box warnings from menopause hormone‑therapy products in November 2025. time.news
  • [○ 1 SOURCE] The Women’s Health Initiative study was stopped early because it suggested hormone therapy increased risk of heart disease, breast cancer, stroke, and pulmonary embolism. time.news
  • [○ 1 SOURCE] 85% of surveyed UK perimenopausal women began looking for information online when symptoms started. vajenda.substack.com
  • [○ 1 SOURCE] Medical groups now recommend menopausal hormone therapy again for many patients. time.news
  • [○ 1 SOURCE] Researchers re‑analyzed the Women’s Health Initiative data and proposed a timing hypothesis that benefits and risks of hormone therapy depend on a woman's age. time.news
  • [○ 1 SOURCE] A survey of more than 900 UK perimenopausal women found 90% had not been taught about menopause in school. vajenda.substack.com